Personalized Medicine Requires a New Approach to Quality Control
Syner-G
JULY 7, 2023
Cell and gene therapies have been subjects of research for some time, but they have gained traction in real-world medicine and are projected to reach a market value of more than $36 billion by 2027. Drug development companies must embrace new technology. Efficient clinical and commercial manufacturing presents issues, too.
52 
Let's personalize your content